Verified Nov 2026
Other
·

Greenford, England
·
Since 2000
GSK plc is a multinational pharmaceutical and biotechnology company headquartered in Greenford, England, founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. With 50,000–100,000 employees and revenue exceeding $10 billion, the company develops specialty medicines, vaccines covering over 20 formulations, and treatments across respiratory health, immunology, oncology, and infectious diseases. Recent activity includes a planned $800 million investment in Pennsylvania to expand its biopharmaceutical capabilities.
GSK at a glance
Revenue
$10B+
Est. band
Employees
50,000-100,000
Founded
2000
Headquarters
Greenford, England
Certifications
IATF 16949
Import activity
1923
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
1923
Named foreign suppliers
27
Top origins
France · Sweden · United Kingdom · Belgium

Shared foreign counterparties do not establish that these companies buy from GSK.
What this tells a buyer
GSK handled 1,923 recorded shipments with supply chains spanning France, the United Kingdom, Switzerland, Sweden, Belgium, Germany, China, India, and other nations, reflecting a distributed manufacturing and distribution network.
The company holds IATF 16949 certification and operates web-listed capabilities in extrusion, coating, and suspension formulation.
GSK employs over 70,000 people globally and operates in approximately 70 countries, positioning it as a major player in global pharmaceutical and vaccine development.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
26 years in operation (founded 2000).
1,923 US import shipments on record.
Holds IATF 16949 certification(s) per public sources.
Overview
GSK plc is a multinational pharmaceutical and biotechnology company headquartered in Greenford, England, founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. With 50,000–100,000 employees and revenue exceeding $10 billion, the company develops specialty medicines, vaccines covering over 20 formulations, and treatments across respiratory health, immunology, oncology, and infectious diseases. Recent activity includes a planned $800 million investment in Pennsylvania to expand its biopharmaceutical capabilities.
At a glance
Attribute | Detail |
|---|---|
Founded | 2000 |
Headquarters | Greenford, England |
Employees | 50,000-100,000 |
Revenue | $10B+ (estimated) |
Certifications | IATF 16949 |
What GSK makes
The company holds IATF 16949 certification and operates web-listed capabilities in extrusion, coating, and suspension formulation.
Products and capabilities described on the company's own site include Extrusion, Coating, Suspension (source: gsk.com).
Certifications
GSK is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
IATF 16949 — dqsglobal.com
Trade and customs footprint
GSK handled 1,923 recorded shipments with supply chains spanning France, the United Kingdom, Switzerland, Sweden, Belgium, Germany, China, India, and other nations, reflecting a distributed manufacturing and distribution network. US customs bill-of-lading records list 1923 inbound shipments across 27 foreign suppliers, with top origins including France · Sweden · United Kingdom · Belgium.
Latest developments
2026-10-09 — Gov. Shapiro Secures Investment from GSK Growing Life Sciences Industry | Commonwealth of Pennsylvania (pa.gov)
2026-10-09 — Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs By Reuters (investing.com)
2026-09-03 — HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug | Reuters (reuters.com)
2026-07-28 — GSK picks Prologis’ buildings for R&D hub in Cambridge | Estates Gazette (estatesgazette.co.uk)
2026-06-09 — GSK to buy US lung cancer drug specialist Nuvalent for £8bn | The Independent (independent.co.uk)
2026-03-09 — GSK and Alfasigma announce agreement on worldwide rights for linerixibat | GSK (gsk.com)
Company details
GSK employs over 70,000 people globally and operates in approximately 70 countries, positioning it as a major player in global pharmaceutical and vaccine development. GSK was founded in 2000, has an estimated 50,000-100,000 employees, and is headquartered in Greenford, England. On the LightSource stability read it is rated "Established & active": 26 years in operation (founded 2000). 1,923 US import shipments on record. Holds IATF 16949 certification(s) per public sources.
Frequently asked questions
What does GSK do?
GSK plc is a multinational pharmaceutical and biotechnology company headquartered in Greenford, England, founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. With 50,000–100,000 employees and revenue exceeding $10 billion, the company develops specialty medicines, vaccines covering over 20 formulations, and treatments across respiratory health, immunology, oncology, and infectious diseases. Recent activity includes a planned $800 million investment in Pennsylvania to expand its biopharmaceutical capabilities.
Where is GSK headquartered?
GSK is headquartered in Greenford, England.
When was GSK founded?
GSK was founded in 2000.
How big is GSK?
GSK has an estimated 50,000-100,000 employees, with revenue in the $10B+ range (estimated).
What certifications does GSK hold?
GSK lists IATF 16949 on its website. Confirm the certified scope for the specific plant producing your part.
Does GSK import from overseas suppliers?
US customs bill-of-lading records show 1923 inbound shipments for GSK, with top origins including France · Sweden · United Kingdom · Belgium.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
